SCHEMBL2906366

SCHEMBL2906366

O=C(Cc1ccccc1)O[CH]c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PAM P19021 1/20 0.52
TSHR P16473 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
AKR1B1 P15121 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
CNR2 P34972 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
LMNA P02545 1/20 0.42
CYP19A1 P11511 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27327415 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1PAMTSHR
SCHEMBL559684 0.80 ALDH1A1 (0.57) ALDH1A1MAPK1L3MBTL1PAMTSHR
Methyl Alcohol SCHEMBL4364856 0.79 TSHR (0.53) ALDH1A1MAPK1L3MBTL1PAMTSHR
Styrene SCHEMBL2229871 0.79 ALDH1A1 (0.47) ALDH1A1MAPK1L3MBTL1PAMTSHR
SCHEMBL9387870 0.78 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1PAMTSHR
SCHEMBL11358699 0.78 RECQL (0.46) ALDH1A1PAMCYP2C9SMN1; SMN2KMT2A
SCHEMBL705231 0.78 TSHR (0.56) ALDH1A1MAPK1L3MBTL1PAMTSHR
SCHEMBL163579 0.78 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1PAMTSHR
SCHEMBL150958 0.78 AOC2 (0.41) ALDH1A1PAMCYP3A4CYP2C9SMN1; SMN2
SCHEMBL2903284 0.78 MEN1 (0.46) ALDH1A1L3MBTL1PAMCYP2C9CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217564-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE XenoPort, Inc. (US) 2010-08-18 EP disclosed
US-20090076147-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE XENOPORT, INC. 2009-03-19 US disclosed
WO-2009033054-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE XENOPORT, INC. (US) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076147-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE ADSL, SLC19A1, SLC25A21 ALDH1A1 1514/4885MAPK1 4819/4885L3MBTL1 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.